Media – Virax Biolabs

Media

Keep up to date with all the latest news and updates from Virax Biolabs.

February 25, 2025

Virax Biolabs Believes Technology Aligns with Unites States Department of Health and Human Services’ Transparency Priority on Vaccine Efficacy

February 21, 2025

“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead

Article by Eleanor Malone

February 19, 2025

“Global Launch Strategies in the Current Political Climate”: Virax CEO, James Foster, discusses how global launches are being impacted by changing geopolitical conditions

Article by Mike Hollan

February 4, 2025

“Lyme Disease: Are we Close to an Effective Diagnostic Test?”: Dr. Nigel McCracken speaks to Clinical Lab Products Magazine

Article by Chris Wolski

January 24, 2025

“Combating chronic inflammation through immune diagnostics”: Dr. Nigel McCracken speaks to Longevity.Technology

Article by Eleanor Garth

December 17, 2024

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

December 10, 2024

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

December 9, 2024

Virax Biolabs: Interview With COO Nigel McCracken About The Diagnostics And Detection Company

by Amit Chowdhry of Pulse 2.0

November 21, 2024

A Diagnosis in Demand – The Urgent Need for Post-Acute Infection Syndrome (PAIS) Testing by Dr. Elihu Aranday-Cortes

November 15, 2024

Discovering Solutions for Long COVID: A T Cell Immunology Breakthrough (feat. Dr. Nigel McCracken)

by Tori Whitacre Martonicz of Infection Control Today

October 24, 2024

Detecting T Cell Dysfunction in Post-Acute Infection Syndromes (feat. Dr. Nigel McCracken)

by Sophia Abene of Contagion Live

October 23, 2024

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland